Acrylamide-induced effects on general and neurospecific cellular functions during exposure and recovery

Basal cytotoxicity, morphological changes and alterations in cell physiological and neurochemical functions were studied in differentiated human neuroblastoma (SH-SY5Y) cells during exposure to acrylamide and during a subsequent recovery period after cessation of exposure. Acrylamide induced a 20% reduction in the number of neurites per cell at 0.21 mmol/L and 20% decrease in the protein synthesis rate at 0.17 mmol/L after 72 h of exposure. Furthermore, the basal level of intracellular calcium concentration ([Ca2+]i) and receptor-activated (carbachol, 0.1 mmol/L) Ca2+ fluxes increased by 49% and 21%, respectively, at 0.25 mmol/L. These observations were made at noncytotoxic acrylamide concentrations, signifying specific neurotoxic alterations. Forty-eight hours after cessation of acrylamide exposure, the SH-SY5Y cells had recovered, i.e., the number of neurites per cell as well as the basal level of [Ca2+]i and rate of protein synthesis were comparable to those of control cells. The general calpain inhibitor calpeptin decreased the acrylamide-induced (0.5 mmol/L) neurite degeneration, determined as reduction in number of neurites per cell, from 52% to 17% as compared to control cells, which further supports the hypothesis that an increased [Ca2+]i plays a significant role for acrylamide-induced axonopathy.

[1]  J. DeJongh,et al.  Estimation of systemic toxicity of acrylamide by integration of in vitro toxicity data with kinetic simulations. , 1999, Toxicology and applied pharmacology.

[2]  C. Calleman,et al.  The metabolism and pharmacokinetics of acrylamide: implications for mechanisms of toxicity and human risk estimation. , 1996, Drug metabolism reviews.

[3]  P. Spencer,et al.  A Review of Acrylamide Neurotoxicity Part I. Properties, Uses and Human Exposure , 1974, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[4]  On the Application of Cultured Neuronal Cell Lines in Neurotoxicological Studies: Implications of Acrylamide-induced Neurite Disintegration , 1983 .

[5]  H. Tilson,et al.  The impact of dose rate on the neurotoxicity of acrylamide: the interaction of administered dose, target tissue concentrations, tissue damage, and functional effects. , 1996, Toxicology and applied pharmacology.

[6]  M. Goldberg,et al.  Calpain Activation Contributes to Dendritic Remodeling after Brief Excitotoxic Injury In Vitro , 1997, The Journal of Neuroscience.

[7]  Tilson Ha The neurotoxicity of acrylamide: an overview. , 1981 .

[8]  L S Freedman,et al.  Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. , 1978, Cancer research.

[9]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[10]  J. Eichberg,et al.  Changes in Na-K ATPase and protein kinase C activities in peripheral nerve of acrylamide-treated rats. , 1994, Journal of toxicology and environmental health.

[11]  G H Sato,et al.  Growth of a rat neuroblastoma cell line in serum-free supplemented medium. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[12]  F. Oehme,et al.  Acrylamide and Polyacrylamide: A Review of Production, Use, Environmental Fate and Neurotoxicity , 1991, Reviews on environmental health.

[13]  Pierluigi Nicotera,et al.  In Vitro Neurotoxicity Testing , 1994 .

[14]  S. Nahorski,et al.  Muscarinic-receptor-mediated changes in intracellular Ca2+ and inositol 1,4,5-trisphosphate mass in a human neuroblastoma cell line, SH-SY5Y. , 1990, The Biochemical journal.

[15]  E. Walum,et al.  Determination of Critical Cellular Neurotoxic Concentrations in Human Neuroblastoma (SH-SY5Y) Cell Cultures , 1995 .

[16]  P. Fullerton Electrophysiological and histological observations on peripheral nerves in acrylamide poisoning in man. , 1969, Journal of neurology, neurosurgery, and psychiatry.

[17]  E. Lehning,et al.  Acrylamide-induced distal axon degeneration: a proposed mechanism of action. , 1994, Neurotoxicology.

[18]  Cavanagh Jb The significance of the "dying back" process in experimental and human neurological disease. , 1964 .

[19]  J. Krieglstein,et al.  Blockade of calpain proteolytic activity rescues neurons from glutamate excitotoxicity , 1997, Neuroscience Research.

[20]  A. Ruusala,et al.  Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbolester-induced differentiation. , 1984, Cell differentiation.

[21]  M. Blaustein,et al.  Physiological effects of endogenous ouabain: control of intracellular Ca2+ stores and cell responsiveness. , 1993, The American journal of physiology.

[22]  P. Spencer,et al.  Ultrastructural studies of the dying-back process. IV. Differential vulnerability of PNS and CNS fibers in experimental central-peripheral distal axonopathies. , 1977, Journal of neuropathology and experimental neurology.

[23]  J. DeJongh,et al.  Neurite degeneration in differentiated human neuroblastoma cells. , 1998, Toxicology in vitro : an international journal published in association with BIBRA.

[24]  J. Cavanagh THE PATHOKINETICS OF ACRYLAMIDE INTOXICATION: A REASSESSMENT OF THE PROBLEM , 1982, Neuropathology and applied neurobiology.

[25]  D. W. Sickles Toxic neurofilamentous axonopathies and fast anterograde axonal transport. I. The effects of single doses of acrylamide on the rate and capacity of transport. , 1991, Neurotoxicology.

[26]  P. Spencer,et al.  Ultrastructural studies of the dying-back process. III. The evolution of experimental peripheral giant axonal degeneration. , 1977, Journal of neuropathology and experimental neurology.

[27]  S. Orrenius,et al.  The role of calcium in the regulation of apoptosis , 1996, Scanning microscopy.

[28]  E. Walum,et al.  Glutathione content, glutathione transferase activity and lipid peroxidation in acrylamide-treated neuroblastoma N1E 115 cells. , 1994, Toxicology in vitro : an international journal published in association with BIBRA.

[29]  S. Orrenius,et al.  Calcium signalling and the regulation of apoptosis. , 1998, Toxicology in vitro : an international journal published in association with BIBRA.

[30]  W. Gispen,et al.  Polyneuropathies and CNS protein metabolism. III. Changes in protein synthesis rate induced by acrylamide intoxication. , 1978, Journal of neuropathology and experimental neurology.

[31]  M. Fehlings,et al.  Pretreatment with Calpain Inhibitor CEP‐4143 Inhibits Calpain I Activation and Cytoskeletal Degradation, Improves Neurological Function, and Enhances Axonal Survival After Traumatic Spinal Cord Injury , 2000, Journal of neurochemistry.

[32]  B. Veronesi,et al.  In vitro screening batteries for neurotoxicants. , 1992, Neurotoxicology.